- Home
- ETD vs KURA Comparison
ETD vs KURA Comparison
Compare ETD & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETD | KURA |
|---|---|---|
| Founded | 1932 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 610.5M | 1.0B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | ETD | KURA |
|---|---|---|
| Price | $23.96 | $11.96 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $28.00 | $25.00 |
| AVG Volume (30 Days) | 298.5K | ★ 1.9M |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | ★ 7.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.85 | N/A |
| Revenue | ★ $607,296,000.00 | $104,029,000.00 |
| Revenue This Year | N/A | $138.16 |
| Revenue Next Year | $3.32 | $67.37 |
| P/E Ratio | $12.98 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $21.67 | $5.41 |
| 52 Week High | $32.61 | $12.49 |
Technical Indicators
Market Signals| Indicator | ETD | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 60.13 |
| Support Level | $23.25 | $10.80 |
| Resistance Level | $24.51 | $12.32 |
| Average True Range (ATR) | 0.63 | 0.66 |
| MACD | 0.33 | 0.01 |
| Stochastic Oscillator | 79.23 | 76.92 |
Price Performance
Historical ComparisonAbout ETD Ethan Allen Interiors Inc.
Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.